Dandekar Atul

CIK 00020501671 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0002050167

Recent Transactions

49 trades

Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-09-03$25.81/sh−36→ 32,316 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-09-03$26.01/sh−3,207→ 32,352 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-09-02$26.38/sh−2,800→ 35,950 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-09-02$27.12/sh−391→ 35,559 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Restricted Stock Units
2026-09-01−12,500→ 12,500 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-09-01+12,500→ 38,750 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-08-28$27.58/sh−7,500→ 26,250 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-08-28−7,500→ 14,143 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-08-28$10.42/sh+7,500→ 33,750 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-07-29$10.42/sh+7,500→ 33,750 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-07-29$27.89/sh−400→ 26,250 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-07-29−7,500→ 21,643 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-07-29$27.31/sh−7,100→ 26,650 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-06-29$10.42/sh+7,500→ 33,750 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-06-29$28.02/sh−7,500→ 26,250 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-06-29−7,500→ 29,143 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-05-29$26.34/sh−7,500→ 24,808 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-05-29$10.42/sh+7,500→ 32,308 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-05-29−7,500→ 36,643 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-05-04−5,985→ 27,725 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-05-04−8,320→ 20,204 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-05-04$10.42/sh+8,320→ 18,823 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-05-04$10.42/sh+5,985→ 24,808 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-04-29$10.42/sh+7,500→ 18,003 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-04-29−7,500→ 44,143 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-04-29$25.37/sh−7,500→ 10,503 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-03-30$10.42/sh+7,500→ 18,003 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-03-30$29.26/sh−6,710→ 11,293 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-03-30$30.02/sh−790→ 10,503 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-03-30−7,500→ 51,643 total
Award
Maze Therapeutics, Inc.$MAZE
Restricted Stock Units
2026-03-02+19,000→ 19,000 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-03-02+38,000→ 38,000 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-27$10.42/sh+7,500→ 18,003 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-02-27−7,500→ 59,143 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-27$45.72/sh−3,761→ 10,503 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-27$45.13/sh−3,739→ 14,264 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-29$43.18/sh−1,200→ 16,803 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-29$10.42/sh+7,500→ 18,003 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-29$44.04/sh−3,500→ 13,303 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-29$45.01/sh−2,800→ 10,503 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-29−7,500→ 66,643 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-12-30−100→ 74,143 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-30$10.42/sh+100→ 10,603 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-30$40.36/sh−100→ 10,503 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-12-29−72,400→ 74,243 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$10.42/sh+72,400→ 82,903 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$40.51/sh−66,365→ 16,538 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$41.13/sh−6,035→ 10,503 total
Award
Maze Therapeutics, Inc.$MAZE
Restricted Stock Units
2025-09-22+25,000→ 25,000 total

Companies

Maze Therapeutics, Inc.
CSBO
$MAZE

Recent Filings

Address

C/O MAZE THERAPEUTICS, INC. 171 OYSTER POINT BOULEVARD, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov